InvestorsHub Logo
Followers 243
Posts 12694
Boards Moderated 0
Alias Born 08/14/2003

Re: datafarer post# 372999

Wednesday, 04/28/2021 2:20:28 AM

Wednesday, April 28, 2021 2:20:28 AM

Post# of 720677
I'm a patient of the head of hematology at City of Hope, they're heavily into research and yet I've given him information on trials I knew were ongoing that he knew nothing about. He was interested in DCVax-L, and even more so when I mentioned Dr. Liau was the lead clinician and developer of the vaccine. He knows Dr. Liau.

My point is that your oncologist, nor any oncologist can possibly know all that's under development. I believe that Dr. Liau's presentation at SNO in 2018 should have impressed anyone who's seen it, but I doubt if even 1% of all oncologists have. Even many brain surgeons who specialize in GBM wouldn't know, why not? Because most oncologists and other specialists look for FDA approvals before looking at products to use. Patients are probably more actively looking at what's in trial than their Doctors. It's not that they're doing a bad job, but existing therapeutics are tried first by most Drs. unless the patient is pro-active about finding experimental trials that may have better outcomes.

I believe that DCVax's have been hiding in plain sight. Dr. Liau has certainly been as open as she's permitted to be about what was being seen in the trials, but remember, the trial was blinded. You can't be precise about the results while a trial is still blinded.

Ask your oncologist friend to look at Dr. Liau's presentation at SNO in 2018 until he can see unblinded data from the trial. See if after reviewing what's happening if he isn't changing his mind. Please don't get me wrong about the work that most oncologists do, my experience is that they're more than willing to have you speak with leaders in the field. I know that mine, who were tied to Cedar Sinai set up the appointment for me with the head of hematology at City of Hope. It's not that they weren't doing stem cell transplants in seniors, they were willing to, but they recognized that COH had far more experience with it and were recognized as a pioneer in that area.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News